VIMOVO

国家: 以色列

语言: 英文

来源: Ministry of Health

有效成分:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

可用日期:

ASTRA ZENECA ISRAEL LTD

ATC代码:

G02CC02

药物剂型:

TABLETS MODIFIED RELEASE

给药途径:

PER OS

厂商:

ASTRA ZENECA AB., SWEDEN

治疗组:

NAPROXEN

疗效迹象:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

授权日期:

2011-12-01